ITGB2 and cancer: As controls, we used mAb to lymphocyte function–associated antigen 1 (LFA-1)/CD11a/CD18, an isotype-matched anti-vWF mAb that does not bind to lymphocytes or cancer cells, and/or mouse IgG.